Neuromodulation Devices Market Share, Size, and Trends by 2030
Neuromodulation Devices Market: Strategic Insights
Neuromodulation Devices Market
-
CAGR (2022 - 2030)9.2% -
Market Size 2022
US$ 5.73 Billion -
Market Size 2030
US$ 11.61 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing demand for nerve regeneration treatments
- Advancements in stem cell and regenerative medicine
FUTURE TRENDS
- Advances in neural regeneration technologies for improved nerve repair
- Integration of gene therapy and stem cell research
OPPORTUNITIES
- Advancements in regenerative medicine for nerve repair
- Expansion in personalized nerve repair solutions
Key Players
- Abbott St Jude Medical Inc
- LivaNova PLC
- Boston Scientific Corporation
- Aleva Neurotherapeutics SA
- Bioventus
- EnteroMedics Inc
- Nevro Corporation
- NeuroPace Inc
- Synapse Biomedical Inc
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type
- Internal
- External
Application
- Deep Brain Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation
Biomaterial
- Metallic
- Polymeric
- Ceramic
End User
- Hospitals
- Clinics
- Home Healthcare